Cooperative clients
Release time:
2023-04-19 23:47
User reviews and feedback:
Nanjing Baidier Biopharmaceutical Co., Ltd. transferred the raw material and capsule development technology of lenalidomide to our company. This technology is mature and stable, with reliable quality. After acquiring the raw material development technology and capsule development technology of this product, our company completed further industrial scale-up production based on this foundation, successfully completed multiple batches of validation production, and passed the bioequivalence study.
Related News